Dr. Danciu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
840 S Wood St
Mc-713
Chicago, IL 60612Phone+1 312-996-1581Fax+1 312-413-4131
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 2009 - 2012
Louis A Weiss Memorial HospitalResidency, Internal Medicine, 2006 - 2009
Carol Davila University of Medicine and PharmacyClass of 2000
Certifications & Licensure
IL State Medical License 2009 - 2026- American Board of Internal Medicine Medical Oncology
Clinical Trials
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
- Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer Start of enrollment: 2016 Jun 30
- Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2 Start of enrollment: 2017 Oct 01
Publications & Presentations
PubMed
- 1 citationsBarriers and Facilitators to Integrating Acupuncture into the U.S. Health Care System: A Scoping Review.Hongjin Li, Juanita E Darby, Ivy Akpotu, Judith M Schlaeger, Crystal L Patil
Journal of Integrative and Complementary Medicine. 2024-12-01 - Reduction in Breast Cancer Death With Adjuvant Chemotherapy Among US Women According to Race, Ethnicity, and the 21-Gene Recurrence Score.Hsiao-Ching Huang, Gregory S Calip, Jennifer Weiss, Yael Simons, V K Gadi
Journal of the National Comprehensive Cancer Network. 2024-01-08 - Feasibility of implementing acupuncture in medically underserved breast cancer survivors (FAB): A protocol.Hongjin Li, Judith M Schlaeger, Crystal L Patil, Oana Danciu, Zhengjia Chen
Contemporary Clinical Trials. 2024-01-01
Journal Articles
- Association of Race/Ethnicity and the 21-Gene Recurrence Score with Breast Cancer–Specific Mortality Among US WomenKent F Hoskins, Oana C Danciu, JAMA Oncology
Press Mentions
First Test of Anti-Cancer Agent PAC-1 in Human Clinical Trials Shows PromiseDecember 22nd, 2022- Study Finds Racial Disparities in Breast Cancer Prognosis TestingJanuary 21st, 2021
Dr. Danciu on Prescreening and Identifying Breast Cancer SurvivorsJanuary 18th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
